Biocept Inc Sustainability Reports
Biocept, Inc. is a molecular oncology diagnostics company that develops and commercializes liquid biopsy assays using standard blood and cerebrospinal fluid samples. The tests utilize proprietary circulating tumor cell and circulating tumor nucleic acid technologies to detect and track cancer.
Sector: Professional & technical services
Country: United States
Exchange: OTC Markets
LEI: 5493000MP9GU5S88NF42
FIGI: BBG001T0B985
3 reports from 2015 to 2020
